Elevatebio ups the ante in cell, gene therapies with $170M series B March 30, 2020 By Randy Osborne No Comments Cambridge, Mass.-based Elevatebio LLC has triple-pronged plans for its $170 million series B round, which the company said will be directed toward manufacturing cell and gene therapies, enabling new technology platforms, and pursuing therapeutics.Read More